OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 Is the current UK flu vaccination effective
  2. 2 For a fit 69 yr old male
  3. 3 Is there a best time to get the vaccine to reduce waning?

Answered on this page ↓

Is there a best time to get the vaccine to reduce waning?

Sep 15, 2026 · 5 sources used · OpenNeedle synthesis
The short version: timing matters, but the benefit is small and the evidence is messy. Getting the shot in late October or early November, about 2-4 weeks before flu season peaks, probably gives you the best chance of protection when you need it most.

The evidence for waning is real but inconsistent. A large US study across four seasons found that protection against H3N2 dropped from 35% at 14 days after the shot to zero at 158 days [1]. Against H1N1 it fell from 80% to 37% over 128 days [1]. A UK study from 2011-12 showed the same pattern: 53% protection if vaccinated less than three months before exposure, falling to 12% if three months or more had passed [4]. But a 2017-18 pediatric study found no waning at all [3], and an Australian study from 2012 also found no significant decline [2]. The difference may come down to which strain is circulating, how well the vaccine matches it, and how the study handles a statistical trap called "depletion of susceptibles" [5].

For a fit 69-year-old man, the practical question is when flu season peaks in your region. In most of the US and Europe, that is January through March. Getting vaccinated in late October or early November puts peak antibody levels right in that window. Vaccinating in August or September risks having protection fade by February [1, 4]. Vaccinating in December or January leaves you unprotected during the early part of the season.

TimingH3N2 protection at 14 daysH3N2 protection at ~5 months
US Flu VE Network [1]35%0%
UK primary care [4]53% (<3 months)12% (≥3 months)
Australian 2012 [2]37% (<93 days)18% (≥93 days, not significant)

The confidence intervals are wide and many estimates are not statistically significant. The evidence supports delaying vaccination until close to the season start, but the benefit of that timing is modest and depends on the year's match.

My call: for a fit 69-year-old man, aim for late October or early November, about 2-4 weeks before local flu season typically peaks. This gives the best chance of protection when flu is circulating. Confidence: moderate.

Keep digging

Sources used 5

  1. Intraseason Waning of Influenza Vaccine Protection: Evidence From the US Influenza Vaccine Effectiveness Network, 2011–2012 Through 2014–2015 Clinical Infectious Diseases (2017) Thin

    Influenza vaccine effectiveness wanes with increasing time since vaccination across influenza A(H3N2), A(H1N1)pdm09, and B viruses, as observed in the US Influenza VE Network from 2011-12 through 2014-15.

    DOI: 10.1093/cid/ciw816
  2. Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: Influences of waning immunity and vaccine match Journal of Medical Virology (2013) primary study Strong

    The 2012 trivalent influenza vaccine provided moderate protection (adjusted VE 45%; 95% CI: 8,66%) against any influenza in Victoria, Australia, with no significant waning over the season, though genetic drift in A(H3) antigenic sites may have limited effectiveness.

    DOI: 10.1002/jmv.23847
  3. Influenza Vaccine Effectiveness Among Children for the 2017–2018 Season Journal of the Pediatric Infectious Diseases Society (2019) primary study Strong

    Influenza vaccine was 52% effective against laboratory-confirmed influenza in children during 2017-2018, was similar against influenza A and B, was not worsened by prior-season vaccination, and showed no evidence of intraseasonal waning.

    DOI: 10.1093/jpids/piz077
  4. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection Eurosurveillance (2013) primary study (observational test-negative case-control study) Strong

    The 2011/12 trivalent seasonal influenza vaccine provided low overall protection (23% adjusted VE) against influenza A(H3N2) infection in UK primary care with significant intraseasonal waning (VE decline from 53% to 12% by time since vaccination), but high protection (92%) again…

    DOI: 10.2807/ese.18.05.20389-en
  5. Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results Epidemiology and Infection (2019) other Strong

    A mathematical analysis shows that restricting influenza vaccine waning studies to persons vaccinated before the influenza season makes a finding of waning robust to depletion-of-susceptibles bias: under the null of no waning the estimate is unbiased, and if waning truly occurs …

    DOI: 10.1017/s0950268819001961

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question